This October, a project screening for atrial fibrillation will commence at the University Hospital in Friborg (HFR Fribourg), Switzerland. The project is the first screening […]
In a recently completed project at Queen Alexandra hospital in Portsmouth twice as many stroke patients received the correct Atrial Fibrillation diagnosis with Zenicor-ECG compared to current standard of care. The aim of the project was to develop and improve the diagnosis of Atrial Fibrillation for stroke patients in Portsmouth and to prevent recurrent strokes. The study was presented at the European Stroke Organisation Conference in Venice.
Zenicor now listed by BNK Service as one of eight selected purchasing partners.
In April the first patients were included in the STROKESTOP 2 study. The aim of the study is to prevent stroke by screening for silent Atrial Fibrillation with Zenicor thumb-ECG and to initiate stroke preventive treatment. The study will include all 75 and 76 year old citizens in Stockholm.
A new large study, STROKESTOP II, will be conducted during 2016 and 2017.
The Norwegian paper Dagbladet puts the spotlight on screening for atrial fibrillation with Zenicor-ECG. READ MORE (Only in Norwegian)
The 24th of November 2015, Arrhythmia watch published an article about Zenicor thumb-ECG. READ THE ARTICLE
Charité University Hospital in Berlin presents a pediatric study with Zenicor EKG. “…an excellent diagnostic device for the detection and exclusion of tachycardia in children.” […]
On October 27, Tijn Hendrikx, general practitioner and MD made a presentation about the use of Zenicor Thumb-ECG. Tijn has done several studies on Zenicor […]
The internationally renowned journals Circulation and Europace have recently published two scientific articles from the Swedish STROKESTOP study on primary preventive screening for atrial fibrillation […]
